Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70434 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Sarah Baklouti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacokinetics and Toxicology, Purpan Hospital, University Hospital of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Milk, Human, Amoxicillin, Models, Biological, Breast Feeding. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Medicines Initiative.
Abstract (Originalsprache)
Aims
Amoxicillin, a widely used β‐lactam antibiotic, requires improved pharmacokinetic characterization during breastfeeding. This study used a population pharmacokinetic (PopPK) approach to model amoxicillin concentrations in breast milk, identify variability sources and estimate infant exposure, applying worst‐case scenarios.
Methods
Breastfeeding mothers receiving amoxicillin for at least 2 days were enrolled. At steady state, three (nearly) paired blood and milk samples were collected between two doses: 15–30 min, 1–2 h and 3–4 h post‐dose. Samples were analysed using LC–MS/MS. PopPK modelling was performed with Monolix. Milk‐to‐plasma (M/P) concentrations ratios and relative infant dose (RID) were evaluated. RID was calculated relative to both adult and paediatric dosing regimens. Monte Carlo simulations estimated infant exposure at high maternal doses (6 g/day).
Results
Twenty‐five mother–infant pairs were included. All plasma and milk samples ( n = 75/matrix) contained quantifiable amoxicillin. A two‐compartment model described the data, with drug transfer from plasma to milk and elimination from milk. Simulated M/P concentrations ratios were 4.1%–5.4%, while observed values ranged from 4.5% to 9.6%. RID based on adult or paediatric dosages remained
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacokinetics and Toxicology, Purpan Hospital, University Hospital of Toulouse, Toulouse, France.
- UMR1436-INTHERES, ENVT/INRAe, Toulouse, France.
- Milkbank, Ile de France, Necker-Enfants Malades Hospital, AP-HP, Paris, France.
- Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
- Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.
ORCID-Profile: Alice Panchaud, Karel Allegaert, Pieter Annaert, Monia Guidi, Peggy Gandia
Förderung
- Innovative Medicines Initiative
Zitieren
APA
Baklouti, S., Rigourd, V., Panchaud, A., Nordeng, H., Allegaert, K., Annaert, P., Huang, M. C., Monfort, A., Guidi, M., & Gandia, P. (2026). Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70434
Vancouver
Baklouti S, Rigourd V, Panchaud A, Nordeng H, Allegaert K, Annaert P, et al. Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70434
BibTeX
@article{Baklouti2026,
author = {Baklouti, Sarah and Rigourd, Virginie and Panchaud, Alice and Nordeng, Hedvig and Allegaert, Karel and Annaert, Pieter and Huang, Miao-Chan and Monfort, Anaelle and Guidi, Monia and Gandia, Peggy},
title = {Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70434}
}
EUVIMED